Home▸Alzheimer's Early Detection Blood Biomarker▸Blood-Based p-Tau217 Alzheimer's Screening Simulator

🩸 Blood-Based p-Tau217 Alzheimer's Screening Simulator

This simulation uses blood-based p-Tau217 as a screening tool for Alzheimer's disease, helping users to identify potential cases through the analysis of tau protein levels in blood samples.

Alzheimer's Early Detection Blood Biomarker2DModerate60 FPS
ptau217-blood-screening-simulator ↗ Open standalone

A Simple Blood Draw Replacing Invasive Diagnostics

Placeholder: comparing venipuncture convenience to PET and lumbar puncture.

  • Plasma: Sample type (Placeholder sub-label)
  • ~5 min: Draw time (Placeholder sub-label)
  • $$$$: PET scan cost (Placeholder sub-label)
  • Invasive: CSF procedure (Placeholder sub-label)

Blood draw workflow placeholder heading

Placeholder: short description of the blood draw pipeline versus imaging.

p-Tau217 as a Proxy for Brain Pathology

Placeholder: phosphorylated tau at 217 reflects amyloid and tangle burden.

  • p-Tau217: Biomarker (Placeholder sub-label)
  • Blood plasma: Source tissue (Placeholder sub-label)
  • Tau tangles: Target pathology (Placeholder sub-label)
  • Immunoassay: Detection method (Placeholder sub-label)

Biomarker biology placeholder heading

Placeholder: short description of tau phosphorylation and blood transit.

Correlating Plasma Levels with PET and CSF

Placeholder: statistical agreement between blood, imaging, and spinal fluid.

  • 0.90+: Correlation (r) (Placeholder sub-label)
  • Amyloid PET: Reference standard (Placeholder sub-label)
  • CSF p-Tau: Secondary standard (Placeholder sub-label)
  • 1000s: Cohort size (Placeholder sub-label)

Correlation study placeholder heading

Placeholder: short description of validation cohorts and scatter agreement.

Interpreting Diagnostic Thresholds

Placeholder: dividing results into negative, intermediate, and positive zones.

  • Low: Negative zone (Placeholder sub-label)
  • Grey area: Intermediate zone (Placeholder sub-label)
  • High: Positive zone (Placeholder sub-label)
  • Yes: Two-cutoff model (Placeholder sub-label)

Threshold model placeholder heading

Placeholder: short description of cutoff derivation and grey zone handling.

Bringing the Test into Primary Care

Placeholder: enabling earlier referral decisions in general practice.

  • Primary care: Setting (Placeholder sub-label)
  • Days: Turnaround (Placeholder sub-label)
  • Faster: Referral impact (Placeholder sub-label)
  • Broader: Access gain (Placeholder sub-label)

Care pathway placeholder heading

Placeholder: short description of screening-to-specialist referral flow.

Placeholder: key insight about scaling screening to general population.
⚙ Under the hood

This simulation uses blood-based p-Tau217 as a screening tool for Alzheimer's disease, helping users to identify potential cases through the analysis of tau protein levels in blood samples.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)